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This study attempted to graft neurotrophin-3 (NT-3) receptor (TrkC) gene modified mesenchymal stem
cells (TrkC-MSCs) into the demyelinated spinal cord and to investigate whether electroacupuncture (EA)
treatment could promote NT-3 secretion in the demyelinated spinal cord as well as further enhance grafted
TrkC-MSCs to differentiate into oligodendrocytes, remyelination and functional recovery. Ethidium
bromide (EB) was microinjected into the spinal cord of rats at T10 to establish a demyelinated model. Six
groups of animals were prepared for the experiment: the sham, PBS, MSCs, MSCs1EA, TrkC-MSCs and
TrkC-MSCs1EA groups. The results showed that TrkC-MSCs graft combined with EA treatment
(TrkC-MSCs1EA group) significantly increased the number of OPCs and oligodendrocyte-like cells
differentiated from MSCs. Immunoelectron microscopy showed that the oligodendrocyte-like cells
differentiated from TrkC-MSCs formed myelin sheaths. Immunofluorescence histochemistry andWestern
blot analysis indicated that TrkC-MSCs1EA treatment could promote the myelin basic protein (MBP)
expression and Kv1.2 arrangement trending towards the normal level. Furthermore, behavioural test and
cortical motor evoked potentials detection demonstrated a significant functional recovery in the
TrkC-MSCs1EA group. In conclusion, our results suggest that EA treatment can increase NT-3 expression,
promote oligodendrocyte-like cell differentiation from TrkC-MSCs, remyelination and functional
improvement of demyelinated spinal cord.
D
emyelination occurs in several disorders in the central nervous system (CNS), including multiple sclerosis
(MS) and spinal cord injury (SCI). Demyelination is an important cause of neurological deficits because it
either delays or blocks impulse conduction1–3. Demyelinated axons can be repaired by remyelination in
both humans4,5 and animals. Indeed, in some experimental models of demyelination repair can be, effectively
complete, achieved either by endogenous Schwann cells1,6 or oligodendrocytes7,8. Moreover, remyelination has
also been achieved by the transplantation of a variety of exogenous myelin-producing cells into experimentally
demyelinated lesions. The role of therapeutic strategies based on cell replacement for demyelination diseases has
been confirmed by numerous studies using myelin-producing cells, such as oligodendrocyte precursor cells
(OPCs)9,10, Schwann cells11 or olfactory ensheathing cells12, and stem cells9.
Bonemarrowmesenchymal stem cells (MSCs) are considered to be themost promising candidate in adult stem
cell-based therapy for nervous system diseases because of their potential for easy collection, rapid proliferation,
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that make MSCs attractive for cell implantation therapies in MS,
including immunomodulation13, neuroprotection14 and cell-replace-
ment15,16. Many studies have shown that MSCs implantation exerts a
therapeutic effect in experimental autoimmune encephalomyelitis
(EAE) or toxin-induced demyelinated models, which is supported
by the evidences of functional repair and extensive remyelination17–19.
Electroacupuncture (EA) which originated in ancient China thou-
sands of years ago is widely used as an adjuvant therapy for many
diseases20–24, especially neurological diseases, including CNS damage
and demyelinating diseases. EA has long been used to treat MS in
traditional Chinese medicine, but the therapeutic mechanism is still
unclear. There is evidence that EA can treat MS through modulating
immune functions24. In this connection, EA on Governor Vessel
(GV-EA) acupoints is commonly used to treat spinal cord injury
because impairment of Governor Vessel is correlated with the
damage of spinal cord in Chinese traditional medicine. Indeed,
GV-EA has been shown to alleviate the secondary damage after
spinal cord injury in animal models21,22,25. Our previous studies have
reported that GV-EA could promote the secretion of neurotrophin-3
(NT-3) in injured spinal cord22,26,27. Other studies have also demon-
strated that EA can increase the expression of some neurotrophic
factors like NT-3, brain-derived neurotrophic factor (BDNF), nerve
growth factor (NGF) and neurotrophin 4/5 (NT-4/5)28,29. NT-3 plays
important roles in oligodendrocyte development30,31. It promotes the
survival, proliferation and differentiation of OPCs, and myelination
in vitro and in vivo32–35.
Our previous study indicated that EA treatment could promote
NT-3 expression, increase the number and differentiation of endo-
genous OPCs, and remyelination in the demyelinated spinal cord27.
However, the number of oligodendrocytes differentiated from the
endogenous OPCs is limited. In addition, it is known that NT-3
promotes the survival and differentiation of cells by preferentially
binding to its receptor TrkC. In this study, we attempted to graft
TrkC gene modified MSCs (TrkC-MSCs) into the demyelinated
spinal cord, to investigate whether EA treatment could promote
NT-3 secretion in the demyelinated spinal cord, and further enhance
grafted TrkC-MSCs to differentiate into oligodendrocytes, remyeli-
nation and functional recovery. We show here strong evidence that
EA treatment can increase NT-3 level of demyelinated spinal cord
and promote the differentiation of TrkC-MSCs into oligodendro-
cyte-like cells and remyelination as well as the nerve conduction
functional improvement of demyelinated spinal cord.
Results
TrkC gene modified MSCs express stably TrkC protein in vitro
and in vivo. MSCs cultures were efficiently transduced with
adenoviral vectors encoding NT-3 receptor (TrkC) (MOI 300;
Fig. 1A). High levels of transgene expression were seen in vitro;
.80% of the cells expressed TrkC after infection of 2 days. TrkC
overexpressing MSCs (TrkC-MSCs) displayed morphology similar
to control MSCs cultures. Transgenic MSCs were analyzed for the
presence of TrkC usingWestern blotting 2 days after adenoviral (Ad)
vector transduction. Ad-TrkC transduced MSCs expressed TrkC
protein, but TrkC protein could not be detected in non-transduced
MSCs (Fig. 1B). In vivo analysis of transgene expression showed that
a large number of TrkC-positive GFP-MSCs were detected within or
nearby the demyelination/graft site of spinal cord in the TrkC-
MSCs1EA group (Fig. 1C–D). Thus, the results indicate that Ad-
TrkC transduced MSCs can express stably TrkC protein in vitro and
in vivo.
TrkC-MSCs graft & EA treatment increase NT-3 level in the
demyelinated spinal cord. Two weeks following EB injection, the
NT-3 concentration in the demyelinated spinal cord segments in six
groups wasmeasured by ELISA. Themean levels of the NT-3 content
in three segments of injured spinal cord were considered in 6 groups
and presented in Fig. 2A. As compared with the sham group, the NT-
3 contents were significantly decreased in the PBS, MSCs, and TrkC-
MSCs groups (p , 0.05). However, the NT-3 contents were
significantly increased in the MSCs, MSCs1EA, TrkC-MSCs and
TrkC-MSCs1EA groups as compared with the PBS group
(p , 0.05). The NT-3 content was significantly higher in the
TrkC-MSCs1EA group than that in the MSCs or TrkC-MSCs
group (p , 0.05). Moreover, NT-3 concentration in the TrkC-
MSCs1EA group was not significantly different from that of the
sham group or MSCs1EA group (p . 0.05). The results indicate
that grafted TrkC-MSCs combined with EA therapy can increase
NT-3 level in the demyelinated spinal cord. These results are
consistent with our previous results22,27. Moreover, our previous
results showed that NT-3 can be produced by neurons, astrocytes,
oligodendrocytes and microglia/macrophages in the transected
spinal cord injury22 and the demyelinated spinal cord27.
Exogenous NT-3 promotes differentiation of TrkC-MSCs into
oligodendrocytes in vitro. In order to detect the effect of NT-3 on
differentiation of TrkC-MSCs into oligodendrocytes, we added
exogenous NT-3 into the cultured MSCs or TrkC-MSCs to
ascertain whether NT-3 could promote the differentiation of
TrkC-MSCs into oligodendrocytes in vitro. The cells were
examined with NG2 and APC immunocytochemistry. The results
demonstrated that MSCs differentiated into NG2 positive OPC-like
cells and APC positive oligodendrocyte-like cells (yellow, Fig. 2C–
N). The percentage of NG2 and APC positive cells was the lowest in
the MSCs group (Fig. 2B–D). Exogenous NT-3 could moderately
promote the differentiation of MSCs into NG2 and APC positive
cells (Fig. 2B, E–F). The percentage of NG2 and APC positive cells
in the NT-31TrkC-MSCs group (Fig. 2B, I–J) was the highest and
Figure 1 | In vitro and in vivo analysis of adenoviral (Ad) vector-
mediated transgene expression. (A) Performing TrkC
immunofluorescence staining, 48 h after infection GFP-MSCs with Ad-
TrkC. More than 80% cultured GFP-MSCs (green) expressed the TrkC
gene product (red, arrows). Scale bar: 20 mm. (B) Transgenic MSCs were
analyzed for the presence of TrkC usingWestern blot, 48 h after Ad vector
transduction. Ad-TrkC transduced MSCs expressed TrkC protein, but
TrkC protein could not be detected in non-transduced MSCs. Gels/blots
were run under the same experimental conditions and b-actin was shown
as a control. The cropped blots images were shown in the full-length blots
are presented in Supplementary Figure 1. (C) In vivo confirmation of Ad
vector-mediated TrkC expression in the GFP-MSCs (yellow) at 30 d after
EB injection. (D) Showing higher magnification of GFP/TrkC/
Hoechst33342 positive MSCs (yellow, arrows) in the rectangle boxes of
(C). Scale bars: (C) 5 80 mm; (D) 5 20 mm.
www.nature.com/scientificreports
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was significantly higher than the other groups (Fig. 2B). Moreover,
the effect of NT-3 promoting the differentiation of TrkC-MSCs into
oligodendrocyte-like cells was prevented by application of K252a (a
specific inhibitor of neurotrophin-related tyrosine kinase) or anti-
TrkC/Fc antibody in the NT-31TrkC-MSCs1K252a (Fig. 2B, K–L)
or NT-31TrkC-MSCs1anti-TrkC/Fc (Fig. 2B, M–N) groups. These
results indicated that NT-3 can promote the differentiation of TrkC-
MSCs into NG2 positive OPC-like cells and APC positive
oligodendrocyte-like cells by binding to its receptor TrkC.
TrkC-MSCs graft & EA treatment improve behavioural outcome
and cortical motor evoked potentials (CMEP).Within 3 days after
EB injection, rats exhibited a staggering and retardant gait in a beam
walking test. Considering the effect of injection procedure itself on
the locomotion, rats in all the groups showed an immediately
elevated error score even in the sham group. Rats receiving PBS
injection showed many error footsteps and the highest error scores
at all-time points (Fig. 3A).With increased time, all the rats showed a
gradual improvement until the end of the experiment at 30 days
following cells graft, but this effect was more pronounced in the
MSCs1EA and TrkC-MSCs1EA group. After MSCs1EA and
TrkC-MSCs1EA treatment, the behavioural function of rats were
significantly improved compared with the PBS group beginning
from the 15th day (p , 0.05, Fig. 3A). After TrkC-MSCs1EA and
MSCs1EA treatment, the animal behaviour gradually recovered
with advancing time so that normal function was restored by the
Figure 2 | (A) NT-3 contents of the demyelinated spinal cords in six groups weremeasured by ELISA at 14 d after EB injection. Compared with the sham
group, the NT-3 contents were significantly decreased in the PBS, MSCs, and TrkC-MSCs groups (* indicates p , 0.05). The NT-3 contents were
significantly increased in the MSCs, MSCs1EA, TrkC-MSCs and TrkC-MSCs1EA groups as compared with the PBS group (# indicates p, 0.05). The
NT-3 content was significantly higher in the TrkC-MSCs1EA group than that in the MSCs group (D indicates p , 0.05). The NT-3 contents were
significantly higher in the MSCs1EA and TrkC-MSCs1EA groups than that in the TrkC-MSCs group (m indicates p , 0.05). Moreover, the NT-3
contents in the theMSCs1EA and TrkC-MSCs1EA groups had no significant difference as compared with the sham group (p. 0.05). Data 5 means 6
SD. (B–N) Exogenous NT-3 promoting the differentiation of TrkC-MSCs into NG2 positive and APC positive oligodendrocyte-like cells. (B) Statistical
analyses showed that the percentage of NG2 and APC positive oligodendrocyte-like cells was significantly increased in the NT-31MSCs, NT-31TrkC-
MSCs, NT-31TrkC-MSCs1K252a or NT-31TrkC-MSCs1anti-TrkC/Fc groups as compared with the MSCs or TrkC-MSCs groups (* indicates p ,
0.01). The percentage of NG2 and APC positive cells in the NT-31TrkC-MSCs group was the highest and significantly higher than other five groups
(# indicates p, 0.01); In addition, the increase of NG2 and APC positive cells in the NT-31TrkC-MSCs group was prevented by application of K252a or
anti-TrkC/Fc antibody (the NT-31TrkC-MSCs group vs. the NT-31TrkC-MSCs1K252a or NT-31TrkC-MSCs1anti-TrkC/Fc groups, m indicates p,
0.01). (C–N) The immunocytochemistry showed that some green MSCs differentiated into NG2 and APC positive oligodendrocyte-like cells (yellow,
arrows) in the MSCs (C and D), NT-31MSCs (E and F), TrkC-MSCs (G and H), NT-31TrkC-MSCs (I and J), NT-31TrkC-MSCs1K252a (K and L)
and NT-31TrkC-MSCs1anti-TrkC/Fc (M and N) groups. Scale bar 5 40 mm.
www.nature.com/scientificreports
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end of the experiment at 30 days. The results suggest that TrkC-
MSCs1EA and MSCs1EA treatment may effectively promote the
functional recovery after the demyelinating injury.
To assess functional recovery following demyelination, CMEP
responses were utilized as an in vivo functional measurement of
axonal conduction in the DF of spinal cord. The latency and ampli-
tude of CMEP were detected for each animal (Fig. 3B). The ampli-
tudemay be regarded to reflect the intensity of action potential which
is determined by the normal common axonal quantity. The latency
reflects the conductive velocity of action potential. As compared with
the sham group, the latency and amplitude of CMEP in the PBS,
MSCs and TrkC-MSCs groups was respectively prolonged and
reduced (Fig. 3B–D). Compared with the PBS group, the latency of
CMEP was significantly shorter and the amplitude was higher in the
TrkC-MSCs1EA group and MSCs1EA group (Fig. 3B–D).
Statistical analysis indicated that the CMEP in the TrkC-
MSCs1EA group displayed higher amplitude than those in the
MSCs or TrkC-MSCs groups (p , 0.05, Fig. 3D). However, there
was no significant difference between the TrkC-MSCs1EA and
MSCs1EA groups (p . 0.05, Fig. 3C–D). The results suggest that
TrkC-MSCs1EA andMSCs1EA treatmentmay effectively promote
the recovery of nerve conduction function after the demyelinated
lesion.
EA promotes grafted TrkC-MSCs to differentiate into oligoden-
drocyte-like cells. The grafted GFP-MSCs transduced with Ad
vectors encoding TrkC could easily be identified with fluorescence
microscopy. LabeledMSCs were mainly found in the demyelination/
graft site of DF of spinal cord and were well integrated with the host
tissue (Fig. 1C–D). In a transverse section of the spinal cord
processed for immunofluorescence labelling, the results showed
that grafted GFP-MSCs differentiated into oligodendrocyte-like
cells. NG2 is one of the markers for OPCs. Many NG2/GFP
positive OPC-like cells were found in the demyelination/graft site
of spinal cord in theMSCs (Fig. 4A1–A3), MSCs1EA (Fig. 4B1–B3),
TrkC-MSCs (Fig. 4C1–C3) and TrkC-MSCs1EA (Fig. 4D1–D3)
groups. In the TrkC-MSCs1EA group, the incidence of NG2/GFP
positive OPC-like cells was the highest with some cells bearing long
extending processes (Fig. 4D1–D3). Cell quantitative analysis
showed the percentage of NG2/GFP positive OPC-like cells was
Figure 3 | TrkC-MSCs graft & EA treatment improve behavioural outcome and cortical motor evoked potentials (CMEP). (A) Comparison of
behavioural scores (error footsteps scores) among the sham, PBS, MSCs, MSCs1EA, TrkC-MSCs and TrkC-MSCs1EA groups. With increased time, all
the rats showed a gradual improvement until the end of the experiment, but this effect was more pronounced in the TrkC-MSCs1EA and MSCs1EA
groups. As compared with the PBS group, * indicates p, 0.05. Data 5 means 6 SD. (B) The waveforms of cortical motor evoked potentials (CMEP) in
six groups. (C) Statistical analysis of the latency of CMEP showed: As compared with the sham group, * indicates p, 0.05; As compared with the PBS
group, # indicates p , 0.05. (D) Statistical analysis of the amplitude of CMEP showed: As compared with the sham group, * indicates p , 0.05; As
compared with the PBS group, # indicates p , 0.05; As compared with the MSCs group or TrkC-MSCs groups, D indicates p , 0.05.
www.nature.com/scientificreports
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highest in the TrkC-MSCs1EA group and lowest in theMSCs group
(p , 0.01, Fig. 4E). Moreover, the percentage of NG2/GFP positive
OPC-like cells in the TrkC-MSCs1EA group was higher than that in
the MSCs1EA group (p , 0.01, Fig. 4E).
In addition, we detected APC (a marker for mature oligodendro-
cyte) and GFP double labelled cells at the demyelination/graft site.
The APC/GFP positive oligodendrocyte-like cells appeared irregular
with some of them distributed in the demyelination sites of DF in the
MSCs (Fig. 5A1–A3), MSCs1EA (Fig. 5B1–B3), TrkC-MSCs
(Fig. 5C1–C3) and TrkC-MSCs1EA (Fig. 5D1–D3) groups. This
feature was most pronounced in the TrkC-MSCs1EA group in
which the majority of APC/GFP positive oligodendrocyte-like cells
displayed long processes (insets in Fig. 5D1–D3). Cell quantitative
analysis showed that the percentage of APC/GFP positive cells in the
TrkC-MSCs1EA group was the highest among all groups (p, 0.01,
Fig. 5E). A feature worthy of note was that the percentage of APC/
GFP positive cells in the TrkC-MSCs1EA group was higher than
that in the MSCs1EA group (p , 0.01, Fig. 5E). The percentage of
APC/GFP positive cells in the TrkC-MSCs group was higher than
that in theMSCs group. The results suggest that TrkC overexpression
was beneficial to the differentiation of MSCs into oligodendrocyte-
like cells.
The confocal imaging showed the differentiation of GFP positive
MSCs grafted into NG2 positive young oligodendrocyte-like cells
(Fig. 6A) or APC positive oligodendrocyte-like cells (Fig. 6B) in
the TrkC-MSCs1EA group. The three-dimensionally reconstructed
immunofluorescence picture displayed the localization of NG2/GFP
andNG2/GFP expression. To further investigate whether the grafted
cells could differentiate into myelin-forming cells in the TrkC-
MSCs1EA group, we performed immunoelectron microscopy using
Figure 4 | Differentiation ofMSCs intoNG2positive young oligodendrocyte-like cells at 30 d followingMSCs graft.GFPpositiveMSCs (green, arrows)
and NG2 (red, arrows) double-labeling show the NG2/GFP positive oligodendrocyte-like cells (yellow, arrows) in the MSCs (A1–A3), MSCs1EA (B1–
B3), TrkC-MSCs (C1–C3) and TrkC-MSCs1EA (D1–D3) groups. Scale bars 5 20 mm. (E) Statistical analyses showed that the percentage of NG2/GFP
positive cells differentiated from grafted cells in the TrkC-MSCs1EA group was higher than that in other three groups (the TrkC-MSCs1EA or
MSCs1EA groups vs. the MSCs or TrkC-MSCs groups, * indicates p, 0.01; the TrkC-MSCs1EA group vs. the MSCs1EA group, # indicates p, 0.01).
(F) The dotted box in a schematic diagram of spinal cord shows the figures site of (A1–D3) in the dorsal funiculus (DF).
www.nature.com/scientificreports
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a GFP antibody. By this, the grafted GFP positive cells were identified
with certainty within the demyelination/graft site and, furthermore,
they were associated with myelin profiles encircling the axons within
the demyelination/graft site (Fig. 6C–E). Some GFP reaction pro-
ducts labelled by high electron-dense gold-particles (Fig. 6F–H,
white arrows) were precisely localized in the cytoplasm and nucleus
of the grafted cell. Taken together, the morphological ultrastructural
evidence suggests that grafted GFP positive cells can differentiate
into myelin-forming cells.
TrkC-MSCs graft & EA treatment promote new myelin forming.
In order to elucidate whether TrkC-MSCs graft combined with EA
treatment could promote remyelination, semithin section and
ultrastructural analysis were performed. We used toluidine blue-
stained semithin sections of demyelinated spinal cord and
classified three kinds of myelin sheath at 30 days: degenerated
myelin (loose, redundant sheaths that form loops), newborn
myelin (remyelination; thinner sheaths and lighter in color) and
normal myelin (compact, thick dark sheaths). There were
numerous normal myelin sheaths in DF of spinal cord in the sham
group (Fig. 7A,a). In contrast, the EB-induced injury site was
predominantly occupied by the demyelinated axons and
macrophages when receiving PBS injection only (Fig. 7B,b).
Although MSCs (Fig. 7C,c) or TrkC-MSCs (Fig. 7E,e)
transplantation also moderately increased the number of newly
formed myelin sheaths, considerable degenerated myelin sheaths
and macrophages still presented in the DF of spinal cord. It is
notable that numerous newborn myelin sheaths were found in the
Figure 5 | Differentiation of MSCs into APC positive mature oligodendrocyte-like cells at 30 d following MSCs graft. GFP positive MSCs (green,
arrows) and APC (red, arrows) double-labeling show the APC/GFP positive oligodendrocyte-like cells (yellow, arrows) in theMSCs (A1–A3),MSCs1EA
(B1–B3), TrkC-MSCs (C1–C3) and TrkC-MSCs1EA (D1–D3) groups. Scale bars 5 20 mm. Insets show higher magnification images of the rectangle
boxes in (D1–D3). (E) Statistical analyses showed that the percentage of APC/GFP positive cells differentiated from grafted cells in the TrkC-MSCs1EA
group was the highest, and higher than that in other three groups (the TrkC-MSCs1EA, MSCs1EA or TrkC-MSCs groups vs. the MSCs group, *
indicates p, 0.01; the TrkC-MSCs1EA group vs. the MSCs1EA or TrkC-MSCs groups, # indicates p, 0.01; the MSCs1EA group vs. the TrkC-MSCs
group, p , 0.05). (F) The dotted box in a schematic diagram of spinal cord shows the figures site of (A1–D3) in the dorsal funiculus (DF).
www.nature.com/scientificreports
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MSCs1EA (Fig. 7D,d) and TrkC-MSCs1EA (Fig. 7F,f) groups.
These newborn myelin sheaths were thinner than those in the
sham group. Quantitative analysis of three kinds of myelin among
five groups showed that the number of normal myelin or newborn
myelin in the MSCs1EA and TrkC-MSCs1EA groups was higher
than that in the PBS, MSCs or TrkC-MSCs groups (p , 0.05,
Fig. 7M).
By electronmicroscopy, many normal, thick and compactmyelins
were found in the sham group (Fig. 7G). In the PBS group, numerous
degenerated myelin sheaths and swollen axons denuded of myelin
sheath were observed in the demyelinated DF of spinal cord
(Fig. 7H). The degenerated myelin sheaths exhibited onion-like
appearance whose myelin lamellae were disorganized and loosened
(Fig. 7H). In contrast, the less degenerated myelin sheaths and new-
born myelin sheaths were common in the MSCs (Fig. 7I) or TrkC-
MSCs (Fig. 7K) groups as compared with the PBS group (Fig. 7H).
Very strikingly, numerous newborn myelin sheaths were found in
the MSCs1EA (Fig. 7J) and TrkC-MSCs1EA (Fig. 7L) groups. In
addition, ultrastructural analysis showed the presence of Schwann
cell forming myelin sheaths (not shown) in the demyelination/graft
site. Schwann cells forming myelin sheaths are identified by the
presence of a nucleus adjacent to the myelin and the outer basement
membrane. This feature is consistent with our previous
observation22,27.
TrkC-MSCs graft & EA treatment promote MBP expression and
Kv1.2 arrangement trending to normal level. NF (marker for
axons)/Kv1.2 (a marker for K1 channels)/MBP (a marker for
myelins) triple-label immunofluorescence staining was performed
to examine the expression and distribution of Kv1.2 and MBP in
the demyelination/graft site. In the sham group, the highly
clustered pattern of Kv1.2 staining was observed in the DF of
spinal cord (Fig. 8A1), and Kv1.2 staining was clustered in the
juxtaparanodal (JXP)-like regions under the myelin sheath along
myelinated axons (Fig. 8A1–A4). The clustered pattern of Kv1.2
staining was decreased or disappeared in the demyelination sites
after EB injection, and the distribution pattern of Kv1.2 staining
was diffuse. In some injury sites, Kv1.2 staining appeared slightly
increased, but not in clusters (Fig. 8B1). The smooth staining
signals were likely contributed by Kv1.2 expression in proliferating
immune cells and demyelinated axons (Fig. 8B1–B4, C1–C4). In
some injury sites in the TrkC-MSCs1EA group, Kv1.2 clusters
Figure 6 | Confocal microscope and immunoelectron microscope images showed the differentiation of grafted MSCs into the oligodendrocyte-like
cells within the demyelination site of spinal cord in the TrkC-MSCs1EA group. (A) The confocal imaging confirmed the colocalization of NG2
expression (red) and GFP positive MSCs (green) grafted. (B) The confocal imaging confirmed the colocalization of APC expression (red) and GFP
positive MSCs (green) grafted. (C) Showing four GFP positive cells giving rise to the myelin profiles encircling an axon respectively. (D, E) Showing the
highermagnification of the rectangle boxes in (C). Some GFP reaction products (gold-particles, white arrows) exist in the nucleus, myelin and cytoplasm
of the grafted cells ((F, G and H) showing higher magnification of the rectangle boxes in (C–E)).
www.nature.com/scientificreports
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were still present but atypical in shape, most likely resulting from
partial remyelination and/or demyelination, as indicated by the
reduction but not complete absence of the MBP positive myelin
staining (Fig. 8D1–D4,E1–E4). Overall, disruption of Kv1.2
clustering was highly restricted to the injury site. In non-injury
areas, Kv1.2 clustering remained normal.
Western blot analysis showed that the levels of Kv1.2 protein were
increased in PBS andMSCs groups as comparedwith the shamgroup
(*p, 0.05, Fig. 8F). As compared with the PBS group, Kv1.2 protein
expression was decreased in the MSCs1EA and TrkC-MSCs1EA
groups (#p, 0.05, Fig. 8F). Conversely, the expression levels ofMBP
protein were decreased in the PBS, MSCs and TrkC-MSCs groups as
compared with the sham group (*p , 0.05, Fig. 8G). As compared
with the PBS group, MBP protein expression was increased in the
MSCs1EA and TrkC-MSCs1EA group (#p , 0.05, Fig. 8G).
Discussion
We reported previously that EA treatment can promote NT-3
expression, and increase the number and differentiation of endogen-
ous OPCs and remyelination in the demyelinated spinal cord27.
However, the number of oligodendrocytes differentiated from the
endogenous OPCs is limited. In addition, it is known that NT-3
Figure 7 | Myelin counting and electron microscopy. (A–F) Toluidine blue-stained semithin sections in the sham (A), PBS (B), MSCs (C), MSCs1EA
(D), TrkC-MSCs (E) and TrkC-MSCs1EA (F) groups. (a–f) Showing higher magnification of the rectangle boxes in (A–F). Scale bars: (A–F) 5 80 mm;
(a–f) 5 20 mm. Basically, many normal myelin sheaths are present in the sham (A and a). In the PBS group, the demyelination site was predominantly
occupied by the demyelinated axons (black arrows) and debris ofmyelin sheaths when receiving EB injection only (B and b). AlthoughMSCs (C and c) or
TrkC-MSCs (E and e) transplantation also moderately increased the number of newborn myelin (remyelination, red arrows), considerable degenerated
myelin (black arrows) still presented in theDF of spinal cord. It is notable that numerous remyelination (red arrows) were found in theMSCs1EA (D and
d) and TrkC-MSCs1EA (F and f) groups. (G–L) Ultrastructural analysis in the sham (G), PBS (H), MSCs (I), MSCs1EA (J), TrkC-MSCs (K) and TrkC-
MSCs1EA (L) groups showed the degenerated myelin (black arrows, exhibiting onion-like appearance whose myelin lamellae were disorganized and
loosened.) and newborn myelin (red arrows, showing thinner thickness of myelin sheaths) in the demyelination/graft site of spinal cord. (M)
Comparation of the number of three kinds of myelin (degenerated myelin, newborn myelin and normal myelin) among five groups (compared with the
PBS group, * indicates p , 0.01; compared with the MSCs or TrkC-MSCs groups, # indicates p , 0.05).
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promotes the survival and differentiation of cells by preferentially
binding to its receptor TrkC. Therefore, in this study, we attempted
to graft TrkC (NT-3 receptor) gene modified MSCs (TrkC-MSCs)
into the demyelinated spinal cord, to investigate whether EA com-
bined with TrkC-MSCs graft treatment could promote NT-3 secre-
tion in the demyelinated spinal cord, and further enhance the grafted
TrkC-MSCs to differentiate into oligodendrocytes, remyelination
and functional recovery in the demyelinated spinal cord. Indeed,
the present results suggest that EA combined with cells graft treat-
ment could increase NT-3 level of demyelinated spinal cord, and
promote oligodendrocyte-like cells differentiation from TrkC-
MSCs and remyelination as well as the nerve conduction functional
improvement in the demyelinated spinal cord.
Multiple sclerosis (MS) animal models include EAE, focal myelin
toxin injection and cuprizone ingestion36,37. EAE exhibits character-
istic features similar to many pathophysiological changes of MS,
including demyelinating antibody attacking axons and increasing
encephalitogenic T cells38–40. However, it has some disadvantages
for experimental studies in view of the unpredictability of demyeli-
nation region and the variability of pathology as the disease pro-
gresses. Hence, it would be difficult to assess the effect of EA
treatment on NT-3 level and differentiation of graftedMSCs. In view
of the above, we have opted focal myelin toxin--EB injection into the
white matter regions including the dorsal funiculus to kill oligoden-
drocytes and astrocytes. This produces a focal area of demyelination
with accurate positioning and gradually results in lesion pathology41.
It is of important significance that it can separate demyelination from
remyelination, a spontaneous regenerative response subsequent to
demyelination42,43. Aside from the demyelination, EB injection also
induces a glia-free environment at its injected white matter of spinal
cord, which was confirmed by our previous results of luxol fast blue
(LFB) and immunofluoresence staining27.We have since successfully
established the demyelinated model induced by EB.
Our earlier work showed that EA could increase NT-3 levels and
promote the differentiation of endogenous OPCs and remyelination
in the demyelinated spinal cord induced by EB27. In the present
Figure 8 | TrkC-MSCs graft & EA treatment promoteMBP expression and Kv1.2 arrangement trending to normal level.NF (green, marker for axons)/
Kv1.2 (red, marker for K1 channels)/MBP (purple, marker for myelin sheaths) triple-label immunofluorescence staining was performed to examine the
expression and distribution of Kv1.2 and MBP in the longitude section containing the demyelination/graft site of spinal cord. (A1–A4) Showing the
highly clustered pattern of Kv1.2 staining were observed in the DF of spinal cord, and Kv1.2 staining was clustered in the juxtaparanodal (JXP)-like
regions under theMBP1 myelin sheath alongmyelinated axons in the sham group. (B1–B4) In the PBS group, the clustered pattern of Kv1.2 staining was
decreased, and the distribution pattern of Kv1.2 staining was diffuse. In some demyelination sites, Kv1.2 staining appeared slightly increased, but not in
clusters (B1). (C1–C4) Showing highermagnification of the rectangle boxes in (B1–B4). (D1–D4) In the TrkC-MSCs1EA group, Kv1.2 clusters were still
present, but not very typical, most likely resulting from partial remyelination and/or demyelination, which were indicated by the reduction but not
complete absence of the MBP positive myelin staining (D1–D4). Overall, disruption of Kv1.2 clustering was highly restricted to the demyelination/graft
site. Scale bars5 20 mm. In non-demyelination areas, Kv1.2 clustering remained normal. (E1–E4) Showing highermagnification of the rectangle boxes in
(D1–D4). (F–G) Western blot analysis of Kv1.2 and MBP expression in the sham, PBS, MSCs, MSCs1EA, TrkC-MSCs and TrkC-MSCs1EA groups.
Gels/blots were run under the same experimental conditions and b-actin was shown as a control. The cropped gels/blots images were shown in the full-
length gels/blots are presented in Supplementary Figure 2. Quantification of protein expression showed: As compared with the sham group, * indicates p
, 0.05; As compared with the PBS group, # indicates p , 0.05.
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study, we attempted to apply TrkC-MSCs graft combined with EA
treatment to further enhance the efficacy of remyelination in the
demyelinated dorsal funiculus of spinal cord. Consequently, we
found that the EA significantly promoted the differentiation of
TrkC-MSCs into oligodendrocyte-like cells, which was accompanied
by elevation of NT-3 level. Very interestingly, the EA effect alone
could increase the NT-3 level (1.94 6 0.22 mg/g) as compared with
the EB (1.10 6 0.14 mg/g) group27. However, the NT-3 level of the
demyelinated spinal cord in the EA1MSCs (3.58 6 0.51 mg/g) or
EA1TrkC-MSCs (3.91 6 0.58 mg/g) groups was further elevated as
compared with EA treatment alone. In our previous study, we
showed that some grafted MSCs were NT-3 immunopositive cells
in the MSCs1EA group27. We consider the increased NT-3 content
in the MSCs1EA or TrkC-MSCs1EA groups was attributed to a
synergistic effect of EA treatment and MSCs transplantation. This
takes into consideration of reports that transplanted MSCs can pro-
duce NT-344 or stimulate neuroglial cells to produce neurotrophic
factors45 in the CNS.
The present results suggest that EA can promote the survival and
differentiation of grafted TrkC-MSCs by increasing NT-3 levels in the
demyelinated spinal cord. NT-3 is a significant member of the neuro-
trophic factors family and plays an important role in regulating the
normal oligodendrocyte development and the quantity of oligodendro-
cytes and myelin regeneration following CNS injury and demyelina-
tion46,47. The TrkC is the high-affinity receptor of NT-3. In vivo studies
utilizing NT-3 and TrkC knockout mice have provided valuable
information with respect to the importance of both ligand and receptor
during development of peripheral nervous system and CNS48–50. In the
present study, in order to examine the effect of NT-3 on the differenti-
ation of TrkC-MSCs, we added the exogenous NT-3 into the cultured
MSCs or TrkC-MSCs to observe whether NT-3 could promote the
differentiation of TrkC-MSCs into oligodendrocytes in vitro. Our results
indicate that NT-3 can promote differentiation of TrkC-MSCs into
oligodendrocyte-like cells. Moreover, the efficiency of NT-3 promoting
the differentiation of TrkC-MSCs was prevented by application of
K252a (a specific inhibitor of neurotrophin-related tyrosine kinase)
and anti-TrkC-Fc IgG. In addition, the immunoelectron microscopy
further demonstrated that the EA could promote grafted TrkC-MSCs to
differentiate into oligodendrocyte-like cells which appeared to enwrap
axons forming new myelins in the demyelination/graft site of spinal
cord. The aforementioned studies have demonstrated that NT-3 bind-
ing to its high-affinity receptor TrkC promotes the differentiation of
TrkC-MSCs into myelin-forming cells. The underlying mechanism is
not fully clear so far. NT-3 does so via two distinct and separable
signaling pathways: the PI3-kinase and MEK pathways [mitogen-acti-
vated protein kinase (MAPK), extracellular signal-regulated protein
kinase 2 (ERK2)], which are common downstream substrates of
TrkC receptor tyrosine kinases33. Studies have also reported that NT-
3 can induce both the survival and proliferation of OPCs and differ-
entiation of oligodendrocytes involving the transcription factor cAMP
response element-binding protein (CREB)46,47.
Interestingly, in this study, we found that EA could promote
grafted TrkC-MSCs differentiated only into oligodendrocyte-like
cells, but not into neurons and astroglia cells (not shown) in the
demyelination/graft site of spinal cord. However, our previous study
showed that EA could promote grafted TrkC-MSCs to differentiate
into neuron-like and oligodendrocyte-like cells in the completely
transected spinal cord22. Comparison of these results suggests that
the differentiation of MSCs overexpressing TrkC may also be regu-
lated by the local microenvironment. The dorsal funiculus of spinal
cord is mainly composed of myelinated nerve fibers and oligoden-
drocytes. It is speculated that the local microenvironment of the
demyelinated region may be more conducive to induce the differ-
entiation of grafted stem cells into oligodendrocytes.
Myelin sheath is critical for the normal functioning of the verte-
brate nervous system. In the CNS, myelin sheaths are produced by
oligodendrocytes. In the present study, the semithin sections and
ultrastructural analysis showed that there were more newly formed
myelin sheaths in the TrkC-MSCs1EA group, and Western blot
analysis further demonstrated that the levels of MBP protein were
increased in the TrkC-MSCs1EA group. In the latter, the following
are possible explanations for the efficient remyelination. Firstly,
grafted TrkC-MSCs differentiate into oligodendrocytes forming
new myelin as evidenced by immunohistochemistry and immunoe-
lectron microscopy. Secondly, the involvement of local endogenous
OPCs in the demyelination/graft site should be considered during
remyelination. Our studies alongwith others have demonstrated that
EA treatment can increase the tissue cAMP level and the expression
of neurotrophic factors, such as NT-3, BDNF and GDNF20,29,51,
which can promote OPCs differentiation into mature oligdendro-
cytes to formmyelin.We reported previously that EA could promote
proliferation and differentiation of endogenous OPCs, and remyeli-
nation in the demyelinated spinal cord injury induced by EB27. Thus,
it is suggested that EA can mobilize endogenous OPCs to repair the
damaged nervous system at least to a certain extent. MSCs may also
activate endogenous progenitor cells and facilitate endogenous CNS
repair52–54. As a corollary, we postulate that TrkC-MSCs combined
with EA treatment could also activate endogenous myelin repair.
Thirdly, it is well established that many demyelinated axons are
acutely remyelinated by Schwann cells in the spinal cord demyelinat-
ing lesion induced by EB injection into the dorsal columns1. By
electron microscopy, we had observed that some Schwann cells
formed myelin sheaths in the demyeliation site of spinal cord.
We have observed many more newborn myelin sheaths accom-
panied by a better behavioural recovery and electrophysiological
improvement in the TrkC-MSCs1EA group. This suggests that
TrkC-MSCs1EA treatment can promote functional recovery by
increasing remyelination.Myelination of axons allows a fast saltatory
conduction of electrical impulses, and provides support both mech-
anically and functionally by cellular communication between the
axon and the oligodendrocyte which produces the myelin sheath.
Demyelination of axons reduces the conduction velocity of nerve
impulses, but also makes the axons vulnerable to degeneration42.
Therefore, the loss of oligodendrocytes and myelin sheaths would
result in severe functional impairment. Although spontaneous
remyelination occurs in chronic demyelinating diseases, such as
MS, the repair process eventually fails, often resulting in long-term
disability55. Studies also demonstrated that remyelination will lead to
restoration of function in clinic MS and experimental models of
demyelination3,56,57. Thus, the above studies have suggested that
the extensive remyelination would form the structural basis for the
electrophysiological and behavioural recovery.
Myelination is a complex process which results in a precise spatial
localization of ion channels on the axonal membrane to ensure rapid
and efficient axonal conduction. The electrophysiological and
immunohistological studies have revealed that in adult mammalian
axons Na1 channels are localized at the node of Ranvier, while K1
channels are covered by myelin sheaths and are restricted to the
juxtaparanodal (JXP) region58,59. It has been shown that the distri-
bution of Na1 and K1 channels is altered in the animal models of
dysmyelinated spinal cord1,60,61 and demyelinating diseases including
MS and EAE58,62. The ion channels are implicated in axon conduc-
tion failure and axonal degeneration62–64. The axonal K1 channels
that hyperpolarize membrane potentials toward the resting level,
play critical roles in regulating the initiation, waveform, frequency
and uni-directional propagation of action potentials65,66. Normally,
K1 channel subunits Kv1.1 andKv1.2 are clustered in the JXP regions
under the myelin sheath along myelinated axons in the brain and
spinal cord67,68. The demyelinated axons exhibit a dispersed distri-
bution of K1 channel subunits Kv1.1 and Kv1.2 with loss of the
characteristic distinction of the juxtaparanodal and paranodal
areas69,70. Moreover, a recent study has indicated that adult neural
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precursor cells (aNPCs) transplantation can successfully form com-
pact myelin, reconstruct nodes of Ranvier and reverse long-term
molecular abnormalities of Kv1.2 and Caspr in the adult dysmyeli-
nated CNS axons60. In the present study, the results showed that
TrkC-MSCs combined with EA treatment could promote myelina-
tion by oligodendrocytes differentiated from grafted cells and endo-
genous OPCs, and ion channel proteins reorganization into near
normal spatial localization along the remyelinated axons.
Therefore, our study indicates that TrkC-MSCs coupled with the
EA treatment can promote remyelination and redistribution of clus-
tered pattern of Kv1.2 to the JXP regions along themyelinated axons,
which is the basic structure of axonal conduction recovery.
In conclusion, EA treatment can promote NT-3 expression in the
demyelinated spinal cord, and further enhance the grafted TrkC-
MSCs to differentiate into oligodendrocyte-like cells, remyelination
as well as ion channel proteins reorganization into near normal
spatial localization along remyelinated axons. It is conceivable that
this would ultimately improve the nerve conduction and behavioural
function of the demyelinated spinal cord.
Methods
MSCs preparation. The methods for the preparation of bone marrow mesenchymal
stem cells (MSCs) have been described in detail in our previous study22. Briefly, the
tibias and femurs of the green fluorescent protein (GFP) transgenic Sprague-Dawley
(SD) rats (male, 2 weeks old, Osaka University, Osaka, Japan) were dissected under
the anesthesia and aseptic conditions. After removing the ends of the bone, a 22-gauge
needle filled with low glucose Dulbecco’s Modified Eagle’s Medium (L-DMEM,
Gibco/BRL, Carlsbad, CA, USA) was injected into the central canal of the bone to
extrude the bone marrow. The solution containing bone marrow was then
centrifuged at 1000 rpm for 5 min. The pellet was resuspended in L-DMEM and
supplemented with 10% inactivated fetal bovine serum (FBS), penicillin (100 U/ml),
and streptomycin (100 mg/ml). The cells were then cultured in a 75-ml cell flask.
After planting the cells for 48 h, the medium was replaced to remove non-adherent
cells. When the adherent MSCs grew to near 70–80% confluency, they were serially
passaged using 0.25% trypsin/0.02% EDTA. After being passaged 3–5 times, the
MSCs were ready for use in transplantation.
Transduction of MSCs with TrkC gene. Recombinant adenoviral vectors of human
tyrosine kinase C (TrkC) gene (Ad-TrkC) were constructed as described in our previous
study22. The recombinant adenovirus was propagated in 293 cells and concentrated on
cesium chloride gradients after standard procedures (according to the BD Adeno-XTM
instruction manual). The titer of the concentrated Ad-TrkC stock, determined by direct
plaque assay, was 2.5 3 1011 plaque forming units (pfu)/ml.
MSCs were infected with Ad-TrkC at a multiplicity of infection (MOI) of 300 for
48 h as reported in our previous study22. After 48 h, the TrkC gene modified MSCs
(TrkC-MSCs) were collected and were ready for use in transplantation. In addition, a
small part of TrkC-MSCs were fixed in 2.5% paraformaldehyde for histochemical
staining. The expression of TrkC was examined by immunofluorescent method. The
primary antibody was mouse anti-human TrkC (15500, R&D), and the secondary
antibody was Cy3-conjugated goat anti-mouse IgG.
A statement identifying the institutional and/or licensing committee
experimental approval. All animal experiments were approved by the Institutional
Animal Care and use Committee of Sun Yat-sen University and performed in
accordance with the guidelines.
Experimental animals, surgery and cells graft. A total of 111 Sprague-Dawley male
(SD) rats (of body weight 250–300 g) were used in this study (Supplementary Table
1). The rats were housed in a temperature-controlled (24 6 2uC) and light-controlled
(12512 light-dark cycle) room with free access to food and water. Prior to
experimental manipulation, rats were allowed to acclimatize to the housing facilities
and were handled daily at least for 3 days. All animals in the experiment were
provided by Experimental Animal Center of Sun Yat-sen University and received
humane care in compliance with the Public Health Service Guide for theCare andUse
of Laboratory Animals. All efforts were made to minimize the number of animals
used and their suffering.
The rats were anesthetized with an intraperitoneal (i.p.) injection of 1% sodium
pentobarbital (40 mg/kg). Dorsal laminectomies were performed at the T9–T10
vertebral level and the dura was sheared open. One microliter of EB (0.1 mg/ml) was
stereotaxically injected into 2 sites (at intervals of about 5 mm, 0.5 ml/site) at the
central line of the T10 spinal dorsal funiculus (DF, at depths of 0.8 and 0.6 mm) using
a 1 ml fixed-needle Hamilton syringe7. In the sham groups, laminectomies and
exposure of the dura were carried out without EB injection. After surgery, all animals
received an intramuscular injection of penicillin (160,000 U/ml/d) and then caged
separately on thick soft bedding.
Before transplantation, 10 mg/mlHoechst 33342 (Sigma) was used to labelMSCs in
the different treatment groups for 2 h. At the 4th day after EB injection, a 1 ml volume
of MSCs suspension (1 3 105/ml PBS) at an infusion rate of 0.5 ml/min was directly
injected into the EB lesion site according to our previous study and by others19,71.
However, in the PBS group, 1 ml PBS was injected instead of cell suspension
(Supplementary Figure 3).
The rats were randomly divided into six groups (n 5 18 for each group, total 108
rats): (1) the sham group, received dorsal laminectomy and exposure of the dura only;
(2) the PBS group, received PBS injection at the 4th day after EB injection; (3) the
MSCs group, receivedMSCs graft at the 4th day after EB injection; (4) theMSCs1EA
group, receivedMSCs graft plus EA treatment at the 4th day after EB injection; (5) the
TrkC-MSCs group, received TrkC-MSCs graft at the 4th day after EB injection; (6) the
TrkC-MSCs1EA group, received TrkC-MSCs graft plus EA treatment at the 4th day
after EB injection.
Electro-acupuncture (EA) therapy. Three days after EB injection, rats were
anesthetized as described above, and the T10 thoracic cord was exposed again for PBS
or cells injection (Supplementary Figure 3). In the MSCs1EA and TrkC-MSCs1EA
groups, rats received EA treatment every other day, beginning at the day following
cells graft for 4 weeks. EA stimulation was performed at two acupoints in Governor
Vessel. Two ‘‘Governor Vessel’’ acupoints were utilized during EA treatment, which
are Jizhong (GV6) and Zhiyang (GV9)27. The acupoint GV6 is located on the
posterior midline and in the depression below the spinous process of the eleventh
thoracic vertebra in prone position. GV9 is located on the posteriormidline and in the
depression below the spinous process of the seventh thoracic vertebra in prone
position, respectively. EA treatment on both GV6 and GV9 acupoints can directly
treat the demyelinated spinal cord. Needles were connected with the output terminals
of an electro-acupuncture apparatus (Model G 6805-2, Shanghai Medical Electronic
Apparatus Company, China). Alternating strings of dense-sparse frequencies (60 Hz
for 1.05 s and 2 Hz for 2.85 s alternately) were used for EA. The intensity was
adjusted to induce slight twitch of the hindlimbs (#1 mA), with the intensity lasting
for 20 min. EAwas administered every other day for 26 days, starting from the fourth
day post-surgery.
Training and behavioural scoring. Prior to EB injection, all animals were trained
until they would cross an elevated 2 m-long, 15 mm-diameter wooden beamwithout
stalling. After PBS and cells injection, all animals underwent behavioural testing and
were videotaped every 3 days for 30 days (Supplementary Figure 3). The placement of
footsteps made by each rat during two traverses of the beam in each direction was
given a score of 0, 1 or 2. A score of 0 was given to each normal step, whereas a minor
error (slight insecurity of foot placement) was scored 1 and amajor error (foot slipped
completely from beam surface) was scored 236,56. Throughout the experiment, both
observers were unaware of which rats had received cells graft or/and EA treatment
and which had not.
NT-3 detected by enzyme-linked immunosorbent assay (ELISA). We reported
previously that NT-3 level at 2 weeks after the spinal cord transection was increased
after EA treatment27. In the present study, we investigated whether cells graft and EA
treatment could induce a higher level of NT-3 in the demyelinated spinal cord. Fifteen
days after cells graft and EA treatment, 30 rats of three groups (n 5 5 for each group)
were anesthetized with 1% sodium pentobarbital (40 mg/kg, i.p.) and transcardially
perfused with 200 ml of ice-cold 0.1 M PB. The demyelinated spinal cord segment
(about 0.5 mm) was excised while the cord was placed on dry ice. The segments were
weighed and then mechanically homogenized in ice-cold 0.1 M PB. Homogenates
were centrifuged for 10 min at 14,000 rpm at 4uC and used for NT-3 ELISA
according to the instructions of the manufacturer (NT-3 Emax Immuno-Assay
System, Boster, China).
Effect of NT-3 on differentiation of TrkC gene modifiedMSCs in vitro. In order to
examine the effect of NT-3 on the differentiation rate of oligodendrocyte-like cells
from TrkC-MSCs, gene-modified cells were prepared first as described above. MSCs
were transfetcted with Ad-TrkC (MOI 5 300), and then bothMSCs and TrkC-MSCs
were adjusted to 2 3 104/ml and cultured in a 24-well plastic plate in L-DMEM
containing 5% FBS (,4000 cells/200 ml/per well). Six experimental groups were
divided for each phenotypic verification: the MSCs, NT-31MSCs, TrkC-MSCs, NT-
31TrkC-MSCs, NT-31TrkC-MSCs1anti-TrkC/Fc and NT-31TrkC-MSCs 1
K252a groups (4 wells/group, including 1 negative control well). In theNT-31MSCs,
NT-31TrkC-MSCs, NT-31TrkC-MSCs1anti-TrkC/Fc and NT-31TrkC-MSCs1
K252a groups, the culture medium contained 20 ng/ml NT-3. In addition, 100 nM
K252a (Calbiochem, Darmstadt, Germany), an inhibitor of neurotrophin-related
tyrosine kinase, was added into the culture medium in the NT-31TrkC-
MSCs1K252a group. In the NT-31TrkC-MSCs1anti-TrkC/Fc group, 0.2 mg/ml
anti-human TrkC/Fc antibody (R&D, USA) was added into the culture medium. The
culture medium was replaced every two days. After 7 days of culture, the cells were
fixed and then immunostained with rabbit anti-a chondroitin sulfate proteoglycan
(neuroglycan 2 (NG2), a marker for oligodendrocyte progenitor cells, 15200,
Millipore, USA) and rabbit anti-adenomatous polyposis coli (APC, a marker for
mature oligodendrocytes, 151000, Calbiochem) overnight at 4uC, followed by
incubation with the corresponding Cy3-conjugated secondary antibodies (15800,
Jackson ImmunoResearch, USA) for 1 h before being rinsed three times with 0.01 M
PBS (pH 7.4). GFP cells (green), Cy3 immunofluorochemically labeled cells (red, for
APC), and double-labeled cells (yellow) were evaluated via a fluorescence microscope
(Leica DMIRB). For each culture well, four randommicroscopic visual fields at 4003
magnification were observed. A total of 12 visual fields were evaluated in each
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experimental group (3 wells/group) and all GFP cells were counted. Differentiated
oligodendrocyte-like cells (NG2 and APC positive) were counted separately and
expressed as the percentage of total GFP cells. Every independent group was repeated
for a total of three times.
Cortical Motor evoked potentials (CMEP). Thirty days after PBS and cells injection,
36 rats (n 5 6 for each group, total six groups) were anesthetized with ketamine
(40 mg/kg) and 1% sodium pentobarbital (30 mg/kg) and stereotaxically fixed. The
sciatic nerves and sensorimotor cortex (SMC) were exposed, and then the stimulation
electrodes were connected to the SMC and the recording electrodes were connected to
the sciatic nerve (Supplementary Figure 3). The cortical motor evoked potentials
(CMEP) were detected by the BL-420E Data Acquisition Analysis System for Life
Science (Taimeng, China). The parameter setting of the CMEP signal is as follows: gain
parameter 2000, time constant 0.01 s, filtering 300 Hz. To elicit a CMEP, a single pulse
stimulation (50 ms in duration at a frequency of 5.1 Hz and with a 5 mV voltage
density) was transmitted through the electrodes. In order to obtain high-quality
waveforms for the CMEP signals, 50 CMEP responses were averaged for each rat.
Immunohistochemical staining. Following the behavioural testing and evoked
potentials recording, 48 rats of 6 groups (n 5 8 for each group) were perfused by 4%
paraformaldehyde in phosphate buffer (pH 7.4). The spinal cord was removed, post-
fixed overnight in the paraformaldehyde and cryoprotected in 0.1 M PB containing
30% sucrose at 4uC. The spinal cord containing the lesion was removed and separated
into rostral and caudal halves. The rostral half was for cryosectioning for cell
morphology and immunohistocytochemistry, and the caudal half was for semi-thin
section and also for electron microscopy. Transverse cryosections (25 mm thickness)
of the spinal cord (n 5 5 for each group) were cut and mounted on gelatin coated
slides for immunostaining. Along with this, longitudinal cryosections (25 mm
thickness) of spinal cord (n5 3 for each group) were also cut andmounted on gelatin-
coated slides for immunostaining.
Primary antibodies used were as follows: mouse anti-green fluorescent protein
(GFP, 15500, Millipore, USA); mouse anti-neurofilament (NF, 15300, Sigma, USA);
rabbit anti-neurofilament (NF, 15300, Sigma, USA); rabbit polyclonal anti-a chon-
droitin sulfate proteoglycan (NG2, a marker for oligodendrocyte progenitor cells,
15200, Millipore, USA), rabbit polyclonal anti-adenomatous polyposis coli (APC, a
marker for mature oligodendrocytes, 151000, Calbiochem); rabbit polyclonal anti-
Kv1.2 (a marker for axonal Kv channel, 1550, Alomone Labs); chicken anti-myelin
basic protein (MBP, a marker for myelin, 15500, Millipore, USA). Cy3-conjugated
goat anti-mouse IgG and Cy3-conjugated rabbit anti-goat IgG (15800, Jackson
ImmunoResearch, USA), FITC-conjugated goat anti-mouse IgG and FITC-conju-
gated goat anti-rabbit IgG (15200, Jackson ImmunoResearch, USA), Dylight 649-
conjugated goat anti-rabbit IgG and Dylight 649-conjugated goat anti-chicken IgG
(151000, Jackson ImmunoResearch, USA) were used as secondary antibodies.
Double immunofluorescence staining was carried out on transverse sections of
spinal cord to assess the survival and differentiation of MSCs grafted. Donor MSCs
were identified by a mouse anti-GFP antibody and visualized with FITC-conjugated
goat secondary antibodies. Rabbit polyclonal antibodies of anti-NG2 or anti-APC were
used to identify the differentiation of grafted MSCs into myelin-forming cells. Sections
were washed three times with PBS and incubated with 10% normal goat serum with
0.3% Triton X-100 in PBS for 30 min at room temperature. Incubation with appro-
priate primary antibodies was performed overnight at 4uC. After repeated washing with
PBS, sections were incubated with their respective secondary antibodies for 1 h at 37uC,
washed with PBS, coverslipped, and examined under a fluorescence microscope (Leica
Microsystem AG, Switzerland). Selected sections were further analyzed with a confocal
Zeiss (LSM710) microscope equipped with argon/krypton laser and ZEN software.
Cell counting was conducted in 10 transverse spinal cord sections from the
demyelinated spinal segment of each animal. The surviving GFP positive, NG2/GFP
positive and APC/GFP positive cells were counted in 3 randomly selected unit areas
(100 mm3 100 mm) in the epicentre of the demyelination/graft site of each section at
4003 magnification. The number of GFP positive cells in the unit areas scrutinized
was considered as the total cell number. The average number of GFP positive cells
from the unit areas was designated as the number of surviving cells and used for
comparison. Differentiated oligodendrocyte-like cells (NG2/GFP positive and APC/
GFP positive cells) were also counted in the unit areas and expressed as a percentage
of total surviving GFP positive cells for use in comparison analysis.
Triple-label immunofluorescence staining was performed in the longitudinal
sections to determine the relationship of Kv channel and myelin associated with the
axons in the epicentre of the demyelination/graft site. Axons were identified by a
mouse anti-NF antibody. The rabbit polyclonal anti-Kv1.2 was used to identify the
axonal Kv channel. The chicken anti-MBP was used to identify the myelin. Triple-
label immunofluorescence staining was further analyzed with a confocal Zeiss
(LSM710) microscope equipped with argon/krypton laser and ZEN software.
Preparation of semi-thin resin sections and ultrathin sections. To quantify myelin
sheaths, we adopted a method similar to that described previously27. Briefly, the
caudal halves of the spinal cords were cut every 2 mm thickness starting from the
epicentre of the demyelination/graft site to get 2 thin blocks (2 mm), and then quickly
post-fixed in a fixative solution containing 2.5% glutaraldehyde for overnight at 4uC.
The blocks were washed in PBS, before being placed in a 2% osmium tetraoxide
(Oxkem Limited, Reading, UK) for 30 min. The blocks were washed again in PBS,
and then dehydrated in a graded series of ethanol concentrations and flat-embedded
in Epon 812. Semi-thin sections were cut using 6 mm glass knives on a Leica RM2065
microtome, placed on polysine slides and stained with toluidine blue (5% in a Borax
solution). Finally the sections were cleared in xylene before being mounted using
neutral balsam. In all groups, 4 semi-thin sections (2 sections selected from each
block, 2 blocks) were selected from each animal (n 5 5 for each group) to perform
remyelination analysis. A total of 20 sections were selected from each group. Three
unit areas (100 mm 3 100 mm) from superficial, middle and deep of the dorsal
funiculus (DF) were selected in each section and examined at 4003 magnification.
Three kinds of myelin sheaths, including degenerated myelin (loose, redundant
sheaths that form loops), newbornmyelin (remyelination; thinner sheaths and lighter
in color) and normal myelin (compact, thick dark sheaths), were respectively counted
within a unit area27. The total number of each kind of myelin sheaths from 12 unit
areas per rat was calculated and compared among different groups. Ultrathin sections
were prepared, stained with uranyl acetate and lead citrate, and examined under a
transmission electron microscope (Philips CM10, Eindhoven, Holland).
Immunoelectron microscopy. Three rats in the TrkC-MSCs1EA group were
perfused intracardially with 0.9% saline followed by 400 ml of fixative consisting of 4%
paraformaldehyde 1 15% saturated picric acid 1 0.1% glutaraldehyde in 0.1 M
phosphate buffer at pH 7.4. The demyelinated spinal cord segments were removed,
postfixed overnight at 4uC in fresh fixative without glutaraldehyde, and subsequently
cut into 100 mm transverse sections on a vibratome. To improve the penetration of
antibodies, vibratome sections were transferred into cryprotectant solution containing
25% sucrose and 10% glycerol in 0.1 M PBS overnight at 4uC, followed by a quick
freeze-thaw in liquid nitrogen three times. After washing with TBS, the sections were
treated for 1 h with 20% goat serum to block nonspecific binding of the antibody. The
sections were immunostained with mouse anti-GFP antibody (15400, Millpore, USA)
for 48 h at 4uC. After washing with TBS, sections were incubated with 6 nm
immunogold-labeled goat anti-mouse IgG antibody for 2 h at room temperature, and
then postfixed with 2% glutaraldehyde in 0.1 M PBS for 20 min. These sections were
washed, and then postfixed with 2% OsO4 in 0.1 M PBS, dehydrated in a graded series
of ethanol concentrations, and flat-embedded in Epon 812. The tissue blocks were cut
into ultrathin sections (70 nm thick) which were collected on formvar-coated nickel
slot grids and stained with uranyl acetate. The sections were examined under the
transmission electron microscopy (Philips CM10, Eindhoven, Holland).
Western blot analysis. After 30 days of surgery, 30 rats (n 5 5 for each group) were
sacrificed. The spinal cord was immediately removed and the demyelinated spinal
segments (0.5 cm) containing the demyelination/graft site were dissected and
homogenized on ice in Western lysis buffer (Beyotime Institude of Biotechnology,
China) containing 1% protease inhibitor cocktail (Sigma, USA) using homogenizers.
Homogenates were centrifuged at 12,000 g for 15 min at 4uC. The supernatant liquid
was collected and stored at 280uC for Western blot analysis. Equal amounts of
protein (50 mg) were then loaded on a 10% SDS polyacrylamide gel (SDS-PAGE) and
followed by electrophoresis for 1 h at 150 V. Proteins were transferred from the gel to
a nitrocellulose membrane for 2 h at 350 mA. After blocking non-specific binding
sites with 5% non-fat milk in TBST (0.5% Tween 20 in TBS) for 1 h at room
temperature, the membranes were incubated with mouse anti-b-actin (151000, cell
signaling, USA), rabbit anti- Kv1.2 (15400, Alomone Labs) and goat anti-MBP
(151000, Santa Cruz) overnight at 4uC, respectively. After washing, the members
were treated with a horseradish peroxidase (HRP)-conjugated secondary antibody
(goat anti-mouse, goat anti-rabbit or rabbit anti-goat, 155000, Jackson, USA) for 2 h
at room temperature, and then washed repeatedly. The protein bands were visualized
by enhanced chemiluminescence (ECL) detection reagents (Applygen Technologies
Inc., Beijing, China), and exposed onto X-films for 1 min. The total intensities of
protein bands were measured and quantified with NIH ImageJ. Background was
subtracted for each band. The b-actin loading ratios were obtained by normalizing
against the sham control band. The Kv1.2 channel alterations were obtained by first
normalizing against their sham controls and further normalizing with the b-actin
loading ratio. All Western blotting experiments were performed in triplicates.
Statistical analysis. Data were given as the mean 6 standard deviation (S.D.). They
were analyzed using one-way ANOVA or repeated-measure ANOVA by statistical
software SPSS17.0. The Least-Significant Difference (LSD) test was applied for post
hoc test with one-way ANOVA. The significance level was set at p, 0.05. Whenever
distributions failed the normality test, non-parametric tests such asMannWhitney (t-
test) were used. Spearman’s Rank Correlation test was used to study the correlation
between different parameters.
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